Your browser does not support iframes.
Globally, bacterial resistance to antibiotics has been increasing dramatically. Combating this growth is a top priority for global public health. There is a particular concern that antibiotics are losing effectiveness faster than they are being replaced by new, innovative drugs, including antibiotics and alternative non-antibiotic approaches to treating and preventing infections. Currently it is estimated that more than 700,000 people die every year as a result of antibiotic resistance. By 2050, this is expected to rise to 10 millideaths annually if this disturbing trend is not curbed.
Following discussions at the World Economic forum in Davos, Switzerland in 2016, the global pharmaceutical industry came together to commit to collective action to:
To date, 98 companies and 11 industry associations in 21 countries have signed this declaration. Teva Pharmaceuticals is proud to be among them. For more information, see ifpma.org.
As a partner to the industry, health associations and regulators in finding solutions to AMR, we commit to:
Through these actions, we aim to be active partners in the fight against AMR and to enable millions of people live healthier, better days.